Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Inventurus Knowledge IPO is 45. Their analysis recommends May Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 45 | May Subscribe |
[Dilip Davda] The company is a technology enabled healthcare solutions provider with a major focus of US, Canada and Australia. IKS marked steady growth in its top and bottom lines for the reported periods. It has created a niche place in the segment and gaining grounds. Based on FY25 annualized earnings, the issue appears fully priced. The company is poised for bright prospects ahead with the rising demand for its services in the areas it is operative. Investors may park funds for medium to long term. Read detail review...
Inventurus Knowledge IPO Reviews, analysis and views by popular members. Read Inventurus Knowledge Solutions Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP